AdisJournals

Adis is a reputable #publisher of over 30 #medical journals and newsletters on drugs or related areas, including other therapeutic or diagnostic interventions.

[AdisJournals @AdisJournals]

Unfortunately, the Editorial Manager system for all Adis journals is down unexpectedly.

We're sorry for any disruption and inconvenience this may cause our users.

We hope functionality will return quickly.

[AdisJournals @AdisJournals]

In this review Rahman, et al., discuss #hypertension management in the Asia-Pacific region. You can read the full article here: https://t.co/PLbpHEcQXy

[AdisJournals @AdisJournals]

In this expert opinion in Pharmaceutical Medicine, Feng Sun, et al. discuss maximizing the value of real-world evidence and fostering a patient-centric ecosystem to accelerate healthcare transformation in China #patientcentric #rwe
https://t.co/ELvXqpux68

[AdisJournals @AdisJournals]

In this post hoc analysis published in Drugs & Aging, O’Dwyer et al. investigate the safety and efficacy of cenobamate for the treatment of focal seizures in older patients. Read the article here: https://t.co/mE8Z3CIKkY #seizures #neurology

[AdisJournals @AdisJournals]

We're excited to be attending this year's European ISMPP meeting!
Check out our booth to learn more about our journals & publication opportunities. #ISMPPEurope2024

[AdisJournals @AdisJournals]

What are Summary of Research Articles? These standalone articles summarise a previously published article minus complex language so non-specialist clinicians and HCPs can gain key information quickly and easily.

[AdisJournals @AdisJournals]

Happy New Year everyone! Here's to a year of #innovation and #research in #medicine! Why not start off the year by checking out our Summary of Research Article (SRA) collection - our newest article type here: https://t.co/6M4usjh7lc

[AdisJournals @AdisJournals]

Happy New Year everyone! Here's to a year of #innovation and #research in #medicine! Why not start off the year by checking out our Summary of Research Article (SRA) collection - our newest article type here: https://t.co/6M4usjh7lc

[AdisJournals @AdisJournals]

Not all breast cancers are alike and neither are their treatments. This #BreastCancerAwarenessMonth check out the latest clinical research on breast cancer treatments here: https://t.co/QlJZ3oXgKk

[Oncology and Therapy @Oncology_Ther]

Recent Advances in Gynecological Malignancies: Focus on ASCO 2023

Read this new editorial here: https://t.co/Cghofililo

[AdisJournals @AdisJournals]

This September is Childhood #Cancer Awareness Month. To see the latest #Research in #Paediatric oncology look here: https://t.co/IK9Mse5ySS

[AdisJournals @AdisJournals]

Want to find the right #journal for your manuscript? We offer a pre-submission service at Adis, completely free of charge, to help you find out which journals are best suited for you. Email [email protected] to get started.

[AdisJournals @AdisJournals]

Who here loves a good #podcast ? Did you know that Adis publishes fully #peer #reviewed and #citable podcast articles? You can listen to our entire collection here: https://t.co/WNQ0Ioo68g

[AdisJournals @AdisJournals]

Looking to publish your research? Here at Adis, we have more than 30 titles to choose from. To learn more, you can find our brochure here: https://t.co/fZ6t3jcITZ

[AdisJournals @AdisJournals]

Please take part in the poll for Infectious Diseases and Therapy! What pathogens/infections would you like to see covered in a new topical collection?

[Infectious Diseases and Therapy @InfectDis_Ther]

🗳️What pathogens/infections would you like to see in our new ‘lesser-known infections’ collection? Please vote below!

For context, the articles will aim to provide a concise summary offering practical guidance on how to diagnose and manage less-common infections

[AdisJournals @AdisJournals]

From Twitter chats to LinkedIn groups, learn how digital opinion leaders are leveraging social media to connect with their peers, share knowledge, and improve patient outcomes: https://t.co/S0DSgXSaxH
#clinicalcare #socialmedia #continuouslearning

[Springer Nature @SpringerNature]

Springer Nature continues its support for OA publishing with its latest TA with @heallinkgr in Greece, which will see authors from 43 academic and research institutions able to publish OA in over 2,300 @Springer_Shop, @AdisJournals & @Palgrave journals: https://t.co/GRzggRcBaW

[Dene Peters @DrugsJournal]

Just published in @DrugsJournal phase 3 PUNCH-CD3 trial results showing RBX2660 is superior to placebo in preventing recurrence of C. difficile infection https://t.co/lsS5S2Igka

[AdisJournals @AdisJournals]

Now published with a video abstract, graphical abstract & PLS: a review discussing the ID and management of treatment-induced cognitive dysfunction in patients with prostate cancer after treatment with second-generation androgen receptor pathway inhibitors https://t.co/IIG0XJ3Gf0

[peter llewellyn @networkpharma]

Everyone welcome >> join our #MedComms webinar this week, 9 November, to talk about Illuminating science for patients and healthcare professionals through plain language podcasts with Caroline Halford, Niamh Clarke, Catherine Elliott and Simon Stones https://t.co/btFPxDfAnz

[Diabetes Therapy @Diabetes_Ther]

Diabetes Therapy are at #EASD2022! Message us if you have any questions or would like to meet us- we'd love to hear from you!